ACT (Anti-Coagulation Therapy) Now, a free educational seminar, will be held on October 15, 2013. StopAfib.org founder, Mellanie True Hills, will be one of the panelists. Learn more at: Online educational seminar, ACT (Anti-Coagulation Therapy) Now, to be October 15, 2013
Read More
StopAfib.org participated in a video series for those living with afib. The latest video, The Top Things You Need to Know When Taking an Anticoagulant, was released on September 29 for World Heart Day. To learn more, and watch the video, go to: StopAfib.org Participates in New Video Series About Atrial Fibrillation and Stroke Risk
Read More
Learn how to get in rhythm and stay in rhythm at the Atrial Fibrillation Patient Conference that will be held in Dallas on November 2, 2013. The conference is for afib patients, their families, and caregivers, and includes presentations by leading afib experts to provide atrial fibrillation patients with more information about living with afib …
Read More
This confirms what we already knew... As reported today at the European Society of Cardiology in Amsterdam: "Women with AF receive less anticoagulation treatment than men despite the fact that they are at greater risk of stroke. The new CHA2DS2-VASc score should be used more stringently, especially in women, to optimise their treatment. Treatment of …
Read More
The European Heart Rhythm Association (EHRA), a part of the European Society of Cardiology (ESC), has launched the Afibmatters.org web site for atrial fibrillation patients. StopAfib.org was honored to collaborate on this site to help meet patient needs. Learn more at: Atrial fibrillation patient website afibmatters.org launched by European Society of Cardiology
Read More
There is interesting new information in an article today regarding the Pope's atrial fibrillation and strokes. It reports that he had a bleeding stroke in 1991, along with a stroke in 2005. The bleeding stroke could certainly explain why he was refusing anticoagulants. Even more interestingly, the article also reports that he had a pacemaker …
Read More
Press Release: Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS® (apixaban) Friday, December 28, 2012 5:46 pm EST PRINCETON, N.J. & NEW YORK--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved ELIQUIS® (apixaban). Please see full Prescribing Information including BOXED WARNING and Medication Guide …
Read More
StopAfib.org is pleased to unveil the Top Ten Atrial Fibrillation Videos of 2012. This year the FIRM ablation interviews with Dr. Narayan topped the list. Other popular topics included stroke prevention, new afib guidelines, sleep apnea, and medications. Stories about efficacy of catheter ablation and surgical procedures, comparisons of rate and rhythm control, and other …
Read More
Good to see the FDA moving on this as we're starting to hear of afib patients with mechanical heart valves getting Pradaxa. Here is the FDA announcement... ISSUE: The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the blood thinner (anticoagulant) Pradaxa (dabigatran etexilate mesylate) should not be used …
Read More
StopAfib.org is pleased to unveil the Top Ten Atrial Fibrillation Articles of 2012. There were many topics of interest this year to the atrial fibrillation patient community. As always, the top interest was atrial fibrillation stroke prevention — that included the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for anticoagulants, the HAS-BLED tool …
Read More